| # | Drug | Count |
|---|---|---|
| 0 | QUETIAPINE | 187 |
| 1 | RIVASTIGMINE | 159 |
| 2 | DONEPEZIL HYDROCHLORIDE | 147 |
| 3 | ASPIRIN | 125 |
| 4 | ASPIRIN 325 MG | 123 |
| 5 | ASPIRIN 81 MG | 123 |
| 6 | ATORVASTATIN CALCIUM | 120 |
| 7 | ESOMEPRAZOLE MAGNESIUM | 91 |
| 8 | FUROSEMIDE | 78 |
| 9 | SIMVASTATIN | 67 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GALANTAMINE HYDROBROMIDE | 19 | 0.0115 |
| 1 | RIVASTIGMINE | 159 | 0.0084 |
| 2 | DONEPEZIL HYDROCHLORIDE | 147 | 0.0040 |
| 3 | ZIPRASIDONE | 12 | 0.0033 |
| 4 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 29 | 0.0021 |
| 5 | EXTENDED PHENYTOIN SODIUM | 20 | 0.0012 |
| 6 | CAPTOPRIL | 10 | 0.0010 |
| 7 | MEMANTINE | 14 | 0.0010 |
| 8 | QUETIAPINE | 187 | 0.0010 |
| 9 | ZIPRASIDONE MESYLATE | 13 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 178 |
| 1 | Cholinesterase Inhibitor [EPC] | 161 |
| 2 | Benzodiazepine [EPC] | 138 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 125 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 108 |
| 5 | Loop Diuretic [EPC] | 83 |
| 6 | Insulin Analog [EPC] | 77 |
| 7 | beta-Adrenergic Blocker [EPC] | 77 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 75 |
| 9 | Thiazide Diuretic [EPC] | 71 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cholinesterase Inhibitor [EPC] | 161 | 0.0084 |
| 1 | Calcitonin [EPC] | 8 | 0.0026 |
| 2 | Insulin [EPC] | 37 | 0.0008 |
| 3 | Blood Viscosity Reducer [EPC] | 3 | 0.0007 |
| 4 | Cardiac Glycoside [EPC] | 48 | 0.0007 |
| 5 | Phosphodiesterase 3 Inhibitor [EPC] | 4 | 0.0006 |
| 6 | Potassium-sparing Diuretic [EPC] | 7 | 0.0005 |
| 7 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 3 | 0.0004 |
| 8 | Parathyroid Hormone Analog [EPC] | 40 | 0.0004 |
| 9 | Anthelmintic [EPC] | 1 | 0.0003 |